Amy Gravino is a certified autism specialist and professional public speaker and writer whose work focuses on sex and sexuality among autistic people. As founder and president of A.S.C.O.T. Consulting, she offers autism consulting and college coaching services for individuals on the spectrum, mentoring services for young adults with autism, and professional presentations for conferences, autism events, schools and professional development workshops. She has an M.A. in applied behavior analysis from Caldwell University in New Jersey. Gravino is working on a book, “The Naughty Autie,” a memoir of her experiences with relationships as a woman on the autism spectrum.
Amy Gravino
Autism consultant
From this contributor
Why it’s time to be honest about autistic women and sex
Misinformation about autistic women and sex is common in the scientific community. A study published this year is a case in point.
Why it’s time to be honest about autistic women and sex
Explore more from The Transmitter
Neuro’s ark: Understanding fast foraging with star-nosed moles
“MacArthur genius” Kenneth Catania outlined the physiology behind the moles’ stellar foraging skills two decades ago. Next, he wants to better characterize their food-seeking behavior.
Neuro’s ark: Understanding fast foraging with star-nosed moles
“MacArthur genius” Kenneth Catania outlined the physiology behind the moles’ stellar foraging skills two decades ago. Next, he wants to better characterize their food-seeking behavior.
Largest leucovorin-autism trial retracted
A reanalysis of the data revealed errors and failed to replicate the results.
Largest leucovorin-autism trial retracted
A reanalysis of the data revealed errors and failed to replicate the results.
NIH scraps policy that classified basic research in people as clinical trials
The policy aimed to increase the transparency of research in humans but created “a bureaucratic nightmare” for basic neuroscientists.
NIH scraps policy that classified basic research in people as clinical trials
The policy aimed to increase the transparency of research in humans but created “a bureaucratic nightmare” for basic neuroscientists.